One-Week semaglutide pause may improve stomach scopes
NCT ID NCT07152756
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 30 times
Summary
This study compares two groups of people having an upper endoscopy: those who stopped taking semaglutide (a diabetes/weight-loss drug) for one week before the procedure, and those who never took it. The goal is to see if stopping the drug reduces leftover food or liquid in the stomach and makes it easier for doctors to see the stomach lining. About 418 adults will take part, and researchers will also check for breathing problems during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.